LF
MRNA icon

Lansforsakringar Fondforvaltning’s Moderna MRNA Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-111,091
Closed -$3.15M – 585
2025
Q1 		$3.15M Buy
111,091
+3,211
+3% +$114K 0.02% 460
2024
Q4 		$4.49M Buy
+107,880
New +$5.16M 0.03% 418

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lansforsakringar Fondforvaltning's MRNA Position: Q2 2025 in Review

Lansforsakringar Fondforvaltning sold out of Moderna (MRNA) in Q2 2025, closing a stake of 111,091 shares — an estimated $3.15M sold.

Lansforsakringar Fondforvaltning first reported a position in MRNA in Q4 2024 and held it in 2 quarters. The position peaked at $4.49M in Q4 2024. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Lansforsakringar Fondforvaltning reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Lansforsakringar Fondforvaltning sold 111,091 Moderna shares in Q2 2025, an estimated $3.15M.
  • Lansforsakringar Fondforvaltning first reported a position in Moderna in Q4 2024 and held it in 2 quarters.
  • Lansforsakringar Fondforvaltning's Moderna position peaked at $4.49M in Q4 2024.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2025, filed 13 Aug 2025.